MEKs, which operate within the ERK cascade, shuttle into the nucleus, but are rapidly exported from this location, forming an apparent cytosolic distribution both before and after stimulation. Two dierent mechanisms have been proposed for the nuclear translocation of MEKs. One of them involves a constant and nonregulated shuttling of MEKs into the nucleus operating both before and after mitogenic stimulation. The other mechanism seems to require the activity of MEKs and is facilitated in response to mitogenic stimulation. Here we show that these two mechanisms may coexist in the same cells. We found that leptomycin B (LMB), a potent inhibitor of nuclear export, induces a nuclear accumulation of MEKs, and this was signi®cantly facilitated by stimulation of LMB-treated cells with EGF, TPA and peroxovanadate. The EGF-stimulated, but not the LMBinduced translocation was attenuated by MEK inhibitors and by using inactive forms of MEK1. We also show that LMB slightly activates the ERK cascade, but this activity only partially induces the nuclear accumulation of MEKs in cells treated by LMB alone. Thus, MEKs translocate into the nucleus by a combination of nonregulated and stimulated processes that contribute to the nuclear translocation of MEKs either in resting cells or upon mitogenic stimulation. Oncogene (2001) 20, 7588 ± 7596.
Introduction
Mitogen-activated protein kinases (MAPKs)/Extracellular signal-regulated kinase (ERK) kinases (MEKs) function within signalling cascades, which regulate a variety of cellular processes including proliferation, dierentiation, development, and more (reviewed in Chang and Karin, 2001 ; Lewis et al., 1998; Pearson et al., 2001; Seger and Krebs, 1995) . The MEKs constitute an evolutionary conserved group of dual speci®city protein kinases that includes three highly homologous (*85%) mammalian isoforms which function in the ERK cascade . These are MEK1a (for the 44 kDa MEK1, also termed MKK1a and MAPKK), MEK1b (for the 41 kDa MKK1b also termed MEK3) and MEK2 (for the 45 kDa MKK2; (Zheng and Guan, 1993) ). The mechanism of MEK1 activation involves protein phosphorylation of Ser 218, and Ser 222, which are important for full MEK activity. Phosphorylation of each one of these residues individually seems to be sucient to cause activation, although Ser 222 may play a bigger role in this activation in vivo (Seger et al., 1994) . MEKs are highly speci®c for the downstream components ERK1, ERK1b and ERK2 (Seger et al., 1992a) . Moreover, MEKs are able by themselves to phosphorylate both regulatory Thr and Tyr residues of ERK, making them members of the small family of dual speci®city protein kinases. The unique speci®city towards the native forms of ERK1, ERK1b and ERK2 suggests that MEKs provide the speci®city of the ERK cascade.
The subcellular localization of MEKs is important for their proper function. MEKs were initially reported to localize primarily in the cytosol, both before and after exogenous stimulation (Lenormand et al., 1993) . However, it has later been shown that MEK1 is able to shuttle into the nucleus, but is rapidly exported from this location by a nuclear export signal (NES, Fukuda et al., 1996; Jaaro et al., 1997) in the MEKs' N-terminal domain to give rise to the apparent cytosolic localization. The exact role of the translocation and whether it occurs in response to extracellular stimulation is still controversial. Our previous results (Jaaro et al., 1997) and results presented by Tolwinski et al. (1999) indicated that activation of the MEK/ERK cascade is required for its nuclear translocation. On the other hand, several publications (Adachi et al., 2000; Fukuda et al., 1997b; Gotoh et al., 1999) provided evidence that the translocation of MEKs into the nucleus is a continuous and unregulated process and that the shuttle out of the nucleus plays a role in the export of ERKs from the nucleus (Adachi et al., 2000) .
Here, we studied the mechanisms of MEK translocation into the nucleus. As previously reported (Adachi et al., 2000) , we found that leptomycin B (LMB), which is a potent inhibitor of nuclear export, caused a slow and continuous nuclear accumulation of MEKs. However, the rate of this nuclear accumulation was signi®cantly enhanced upon EGF stimulation. Only this facilitated (but not the LMB-induced) nuclear translocation was aected by the inhibition of MEK activity. Thus, in similarity to ERKs , MEK can shuttle into the nucleus by two coexisting mechanisms. One of them involves a nonregulated diusion and the other is a facilitated process that occurs in response to extracellular stimulation, and requires activation of the MEK/ERK cascade.
Results

LMB induces nuclear localization of GFP ± MEK1 in resting cells
We have previously shown that MEK1 translocates into the nucleus in response to extracellular stimulation (Jaaro et al., 1997) . In order to characterize the nuclear translocation of MEK we have fused a green uorescent protein (GFP) to the C-terminus of MEK1 to enable an easy detection of its subcellular localization. In similarity to endogenous MEKs, expression of the GFP ± MEK1 in Rat1 cells resulted in its cytoplasmic localization, which was not signi®cantly changed upon EGF or phorbol ester stimulation ( Figure 1 ). This localization was dierent from that of GFP alone that was found localized all over the cells both before and after mitogenic stimulation (data not shown). The fusion of the GFP did not change the activation and activity of MEK1 in response to exogenous signals (data not shown), indicating that this construct can serve as a good tool in the study of the subcellular localization of MEKs. Since the export of MEKs out of the nucleus seems to occur in a fast rate, we used LMB, which inhibits the export of MEKs from the nucleus (Fukuda et al., 1997a) , to enable the detection of the nuclear import of MEK1. In order to study the in¯uence of LMB on the localization of MEKs we transfected the GFP ± MEK1 into Rat1 cells, serum-starved the cells for 18 h, ®xed the cells and detected the distribution of the GFP ± MEK1 using¯uorescent microscopy. As mentioned above, GFP ± MEK1 was distributed in the cytosol of all the transfected cells (Figure 1 , no treatment), and this was not changed 48 or 72 h after transfection (data not shown). However, when LMB was added to the cells, the localization of the tagged protein was changed, and a larger amount of it distributed to the nucleus (Figure 1 ). To examine the potency and speci®city of the translocation, we then performed dose response and time course studies. Since the translocation process is not synchronized, the amount of translocated MEK could vary between cells at any given time. In order to account for this variation we counted 100 ± 200 cells at any condition used, and classi®ed the apparent MEK localization to three categories, (i) mostly cytosolic (C4N), (ii) equally distributed (C=N), and (iii) mostly nuclear (C5N). Our results indicate that nuclear translocation of MEK1 could be detected when the concentration of LMB used was as low as 0.1 ng/ml, 60 min after treatment (10 ± 15% equal distribution). The nuclear localization of MEK1 increased in a time-and dosedependent manner and the translocation 1 h after treatment was maximal with 41 ng/ml LMB (up to 80% nuclear). The kinetics of translocation was not changed even when higher concentrations of LMB were added to the cells, indicating that as previously observed for ERKs (Reszka et al., 1995) , a small portion of MEK1 is retained in the cytosol and does not translocate into the nucleus.
EGF facilitates the nuclear translocation of MEKs
Nuclear translocation of ERKs is facilitated by exogenous stimulation (Chen et al., 1992; Lenormand et al., 1993) , and therefore we undertook to study whether this is also the case for the nuclear translocation of MEKs. Indeed, we found that the rate of GFP ± MEK1 translocation in response to EGF+LMB was much faster than that detected with LMB alone ( Figure  2 ). Thus, 15 min after the addition of LMB alone, signi®cant translocation was detected in 20% of the cells, while the addition of LMB together with EGF induced signi®cant nuclear localization in 55% of the cells. Moreover, at this time point, the per cent of cells in which MEK1 was localized primarily in the nucleus was fourfold higher when EGF was added to the LMB than the cells stimulated with LMB alone. Signi®cant dierences were detected also 30 min after treatment, when translocation was detected in 80% of the cells stimulated with EGF+LMB rather than 45% in those stimulated with LMB alone and no translocation in the EGF alone. Again, the percentage of cells exhibiting nuclear localization of MEK1 (N4C) was 3 ± 4-fold higher in the EGF+LMB treatment. This result was not changed much after prolonged stimulation, as the percentages of translocation 2 h after EGF+LMB treatment remained essentially the same (*80%).
The synergistic eect on MEK1 translocation was not unique to the EGF+LMB-stimulated Rat1 cells. In similarity to the EGF treatment, addition of TPA alone to Rat1 cells did not signi®cantly change the apparent cytosolic distribution of the GRP ± MEK1 (Figure 2c ). However addition of TPA to LMB treated Rat1 cells increased the number of cells with any amount of nuclear translocation (all cell with nuclear staining including some C4N and all C=N and C5N) of GFP ± MEK1 from *30% with LMB alone to *75%. The general activator peroxovanadate also increased the amount of translocation but its eect was slightly smaller than that of EGF and TPA and reached up to 60% translocation upon treatment of the Rat1 cells with VOOH+LMB ( Figure 2c ). Moreover, a signi®cant increase in the amount of translocation was detected also in COS7 and HeLa cells. In both of them EGF alone did not change the basal cytosolic distribution of GFP ± MEK1 (Figure 3 ) but increased the LMBinduced translocation from *35% to *80%.
The use of LMB enabled us to study not only the translocation of overexpressed protein, but also the translocation of endogenous MEKs. Thus, either LMB alone or EGF+LMB were added to Rat1 cells and the distribution of the endogenous MEKs was detected by staining the cells with anti-MEKs antibody. In basal state, MEKs were localized exclusively in the cytosol, and as expected (Jaaro et al., 1997) , addition of EGF to the cells did not cause any signi®cant change in this subcellular localization (Figure 4 ). However, in Figure 2 Mitogenic stimulation facilitates LMB-induced nuclear translocation of GFP ± MEK1. (a) A plasmid containing GFP ± MEK1 was transfected into Rat1 cells as described under Materials and methods and grown for 4 h in 10% FCS in DMEM. The cells were then starved for 18 h and treated with LMB (5 ng/ml), EGF (50 ng/ml) or combination of both (LMB with EGF) for the indicated times. The cells were ®xed and visualized by a confocal microscope as described. (b) The cells were classi®ed into three categories according to the GFP ± MEK1 distribution as in Figure 1 . The results shown here are presented as mean+standard error of three independent experiments. (c) The GFP ± MEK1 transfected and starved cells were either left untreated (N), treated with EGF (50 ng/ml, E), TPA (250 nM, T) peroxovanadate (200 mM H 2 O 2 and 100 mM Na 3 VO 4 , V) LMB (5 ng/ml) or with combination of the EGF, TPA and peroxovanadate together with LMB for 15 min. Per cent translocation was calculated as the number of cells with nuclear accumulation (including some C4N and all C=N and C5N) per total number of cells. The data represent the average of two independent experiments Stimulated and non-regulated translocation of MEK Z Yao et al similarity to the exogenous GFP ± MEK1 showed above, LMB induced a higher nuclear localization (*15% in 15 min and 25% in 30 min), and the translocation detected after the EGF+LMB treatment was higher, reaching*50% after 15 min and *80% 30 min after stimulation. This clearly indicates that both an LMB-induced and a faster EGF-induced nuclear translocation mechanisms coexists for the endogenous MEK, and this phenomenon is not con®ned to the exogenous GFP ± MEK1 only.
Role of MEK activity in its nuclear accumulation
The induction of a fast nuclear translocation of MEKs by EGF prompted us to examine the role of activation and kinase activity of MEK1 in this process. To this end, either K97A ± MEK1 or S218,222A ± MEK1 was transfected into Rat1 cells and this was followed by serum deprivation for 18 h and treatments with LMB and EGF as above. The translocation of both mutants of MEK1 was not dierent from that of wild type (WT)-MEK1 upon LMB treatment, but was signi®cantly reduced when LMB+EGF were added to the cells (Figure 5a ). Similar results were obtained when MEK inhibitors PD98059 or U0126 were added to the cells 15 min prior to LMB and EGF (Figure 5b ). These results clearly indicate that activity of MEKs is essential for the EGFinduced nuclear-translocation of MEK1 but not for the slow, non-regulated rate, induced by LMB alone. Taken together, the above data indicate that both nonregulated and stimulated mechanisms may cooperate in the nuclear accumulation of MEK1.
Activation of ERKs and MEKs by LMB
The fact that LMB induces nuclear localization of GFP ± MEK1 in resting cells could be explained by a Figure 4 Mitogenic stimulation facilitates LMB-induced nuclear translocation of endogenous MEKs. Serum-starved Rat1 cells were either left untreated or treated with EGF (50 ng/ml), LMB (5 ng/ml), and combination of both for 30 min. After ®xation and permeabilization, the cells were stained with anti-MEKs antibody followed rhodamine-conjugated antibodies as described under Materials and methods. Similar results were obtained in ®ve independent experiments constant, non-regulated, shuttle of MEK1 in and out of the nucleus as proposed by Adachi et al. (2000) . However, since the nuclear accumulation of MEKs is facilitated by their activation, additional possibility is that the LMB by itself activates MEKs and induces the translocation. In order to test the latter possibility, we treated Rat1 cells with LMB and analysed the activity of components of the ERK and MEK cascade 5 to 30 min after the treatment. A small increase in the phosphorylation of ERKs was detected 10 ± 15 min after the addition of LMB in a dose dependent (reached maximum at 10 min after the addition of 1 ng/ml LMB) manner (Figure 6 ). This was re¯ected also in the catalytic activity of ERK towards myelin basic protein (MBP) and in an`upshift' of ERK1 and ERK2 on an 10% SDS polyacrylamide gel. All these changes were reduced back to basal level 30 min after treatment. The short and brief nature of activation of ERKs and MEKs suggests that although localization of MEK1 in response to LMB could have been induced by this activation, a basal, unstimulated nuclear shuttle should exist at least in later stages after activation. Moreover, the activation of ERKs and MEKs by LMB was signi®cantly lower than the Figure 5 Inhibition of MEK activity attenuates the EGF+LMB-induced, but not the LMB-mediated nuclear translocation of MEK1. (a) Rat1 cells were transfected with GFP ± MEK1 (WT), GFP-K97A ± MEK1 (KA), and GFP-S218,222A-MEK1 (AA). After serum-starvation (18 h), the cells were either left untreated (Basal) or were treated with LMB (5 ng/ml), and with LMB (5 ng/ml) + EGF (50 ng/ml) for 30 min. Transfected cells were counted and categorized according to GFP ± MEK1 distribution as in Figure 1 . The results shown here are presented as mean+standard error of three independent experiments. (b) Rat1 cells were transfected with GFP ± MEK1 and serum starved for 18 h as described. The cells were preincubated with PBS control (5 ml, Con), PD98059 (25 mM, PD) or with U0126 (10 mM) for 15 min at 378C. Each of these treatments were then either left unstimulated (Basal) or treated with LMB (5 ng/ml) and with LMB (5 ng/ml) + EGF (50 ng/ml) for 30 min at 378C. The cells were categorized according to their GFP ± MEK1 localization as above. The results shown here are presented as mean+standard error of three independent experiments Figure 6 Activation of ERKs by LMB. (a) Time course. Rat1 cells were serum-starved for 18 h and treated with LMB (5 ng/ml) or with EGF (50 ng/ml) for the indicated times. Cell extracts were immunoblotted with anti-diphospho ERK antibody (a-DP-ERK) and anti-general ERK antibody (a-gen.ERK). Alternatively, ERKs were immunoprecipitated with anti-ERK C-terminus antibody and their in vitro activity towards MBP was determined as described under Materials and methods (MBP phos.). This is a representative experiment that was reproduced ®ve times (b) Dose response. Rat1 cells were serum-starved for 18 h and treated with the indicated concentration of LMB or with 50 ng/ml EGF for 10 min. The lysates were subjected to immunoblotting with diphospho ERK antibody (a-DP-ERK) and anti-general ERK antibodies (a-gen.ERK). Similar results were obtained in three independent experiments. The sites of migration on the SDS ± PAGE of ERK1, ERK1b and ERK2 and MBP are indicated. (c) Methanol, which is used to solubilize LMB does not activate ERK. Rat1 cells were serum-starved for 18 h and treated with 0.07% methanol (MeOH, which is the same concentration added together with LMB) for the indicated times and subjected to Western blotting with a-DP-ERK and a-gen.ERK. Similar results were obtained in three experiments Stimulated and non-regulated translocation of MEK Z Yao et al activities after EGF or EGF+LMB treatments ( Figure  7) . Therefore, although some of the translocation of MEK1 might occur due to LMB-induced activation, this is probably not sucient to induce its full translocation. Thus, the nuclear accumulation of MEKs at the later stages after the addition of LMB should be independent of their activity, and is likely to be indeed due to a non-regulated process.
Discussion
The mechanism by which MEKs translocate into the nucleus is not yet fully understood. These kinases do not contain a nuclear localization signal (NLS; Akey, 1991) and two dierent types of mechanisms have previously been proposed for their nuclear translocation. Nishida and coworkers proposed a constant, nonregulated shuttling of MEKs into the nucleus of either resting or stimulated cells by a passive diusion (Adachi et al., 2000) . This suggestion was based mainly on the inability of a big fusion protein, b-gal ± MEK, to translocate into the nucleus. On the other hand, results by us (Jaaro et al., 1997) and others (Tolwinski et al., 1999) indicated that the translocation of MEK1 is dependent on its activity and is facilitated in response to mitogenic stimulation of the cells, which was dependent on the phosphorylation of MEK1 on its regulatory S218 and S222 and on signalling downstream of MEKs. Interestingly, in the current study we ®nd that the two mechanisms may in fact coexist to ensure the full nuclear incorporation of MEKs. Thus, when the inhibitor of nuclear export, LMB, was added to resting cells, it induced a slow but signi®cant nuclear incorporation of both GFP ± MEK1 and endogenous MEKs (Figures 1 and 4) . Surprisingly, LMB not only inhibited nuclear export, but also induced activation of the ERK cascade (Figures 6 and 7) . The stimulatory eect of LMB suggests that it may also induce the activity of a putative nuclear transport system, which is then able to mobilize MEKs into the nucleus. However, in spite of a continuous MEKs translocation that peaked only 2 ± 3 h after LMB treatment, the activation of the ERK cascade was much weaker than that induced by EGF, and it reduced back to basal level within 20 ± 30 min ( Figure 6 ). Therefore, although activation of a transport mechanism can not be completely ruled out, it is likely that the translocation of MEKs, at least in the later times after LMB treatment, is a constant and non-regulated process previously suggested to be a passive mechanism (Adachi et al., 2000) . A similar non-regulated mechanism of nuclear transport was suggested also for PKA (Harootunian et al., 1993) and more recently also for ERKs (Adachi et al., 2000) as will be discussed below. We also show here that this non-regulated diusion does not involve phosphorylation of MEK1 in its activation loop and MEK-induced activity, since nuclear translocation induced by LMB was not in¯uenced by inactive mutants of MEK1 or by the MEK inhibitors PD98059 or U0126 ( Figure 5 ). In addition to the non-regulated diusion, MEKs appear to translocate into the nucleus also by a facilitated mechanism, which is induced by extracellular stimulation. This is demonstrated here by the large increase in GFP ± MEK1 containing nuclei after EGF was added to Rat1 cells together with LMB (Figure 2 ). An induced translocation was obtained also with other cell types and with endogenous MEKs upon EGF+LMB treatment (Figures 3 and 4) as well as with other stimuli in Rat1 cells (Figure 2c ). Interestingly, the eect observed with the endogenous proteins was even stronger than that obtained with the exogenous GFP ± MEK1. Thus, full nuclear translocation of endogenous MEKs in 30 min of EGF+LMB treatment was observed in *80% of the cells compared to only *20% of full translocation in the transfected cells (Figure 2 ). In addition only *35% of the transfected cells showed full translocation of GFP ± MEK1 within 2 h from treatment (data not shown). The reason for the big dierence in the amount of translocation is not clear as yet. One possibility is that importins that are required for the translocation are retained in the nucleus due to the addition of LMB and therefore are not available to transport the larger amount of GFP ± MEK1 molecules. On the other hand, it is possible that the rate of GFP ± MEK1 translocation is slower than that of the endogenous MEKs due to the dierences in their molecular weight. This can explain the inability of the very big b-gal ± MEK1 to enter the nucleus in response to stimulation as previously described (Adachi et al., 2000) .
The fact that the EGF-induced, but not the LMBmediated, nuclear translocation of MEKs was inhibited by inhibitors of MEKs clearly supports the coexistence of two mechanisms of translocation. These are a nonregulated translocation, which is not related to MEK activity, and a facilitated mechanism, which involves activity of MEK as well as signalling through the ERK cascade. This situation seems to be similar to the two mechanisms of nuclear translocation recently reported for ERKs . In that study it was suggested that monomeric ERKs enter the nucleus by a passive diusion whereas dimeric forms of ERKs, which are formed upon activation, enter the nucleus by an active transport mechanism. Although MEKs themselves are probably not dimerized upon stimulation, it is possible that a similar set of proteins and molecular mechanisms are responsible for the translocation of both ERKs and MEKs into the nucleus. Another possibility is that a constitutively active mechanism is responsible for the translocation of ERKs and MEKs both before and after stimulation. The enhanced rate of nuclear incorporation after stimulation might then be determined by a faster rate of diusion of MEKs that are released from their anchorage to ERKs or to some other cytosolic molecules. The nature of the proteins and the mechanisms that are involved in the translocation have yet to be elucidated.
The exact role of the translocation of MEKs into the nucleus is not yet fully understood. It was previously reported (Fukuda et al., 1997b ) that disruption of the NES of MEK1 caused morphological changes and foci formation of ®broblastic cells, and these eects were reversed by fusing NES to the N-terminus of MEK1. Two molecular roles for the subcellular localization of MEKs have been previously proposed, an anchorage of ERKs in the cytosol (Fukuda et al., 1997c) and export of ERKs from the cytosol (Adachi et al., 2000) . These proposed functions seem problematic in view of our ®ndings here that clearly demonstrate a fast translocation of most of the MEK molecules into the nucleus upon stimulation. This should be followed under normal conditions by an export of MEKs out of the nucleus, in kinetics that is much faster than the export of ERKs from the nuclei of Rat1 cells (1 ± 3 h after stimulation). In addition, the estimated amount of MEKs in Rat1 cells is much lower than that of ERKs, and makes it unlikely that MEKs can be responsible for the export and anchorage of a signi®cant portion of ERK molecules in these cells. It is therefore possible that the translocation of MEKs plays a role in the activation of nuclear isoforms of ERKs such as ERK1b that was recently identi®ed in our laboratory (Yung et al., 2000 (Yung et al., , 2001 . Alternatively, it is still possible that other substrates for MEKs may exist in the nucleus and those are directly phosphorylated by the shuttling MEKs. In spite of the unique speci®city of MEKs (Jaaro et al., 1997; Seger et al., 1992a) , our preliminary observation indicate that one or two nonkinase nuclear targets for MEKs may indeed exist in Rat1 cells (data not shown).
In summary, we showed here that MEKs translocates into the nucleus by two coexisting mechanisms.
One is a non-regulated process with a slow rate that occurs in resting cells and does not require activation of MEKs or signalling through the ERK cascade. The other is much faster, occurs by a mitogen-stimulated mechanism and requires activation of the ERK cascade. In both incidences, MEKs are rapidly exported back to the cytosol by a CRM1-dependent mechanism, and this causes the apparent cytosolic localization of MEKs observed in both resting and stimulated cells.
Materials and methods
Materials and antibodies
Anti-diphospho ERK mAb, anti ERK pAb (C-terminus), EGF, TPA, LMB and MBP were from Sigma. Anti-MEK C-18 polyclonal antibody and anti-ERK1 C-16 polyclonal antibody were purchased from Santa Cruz Biotechnology, Inc. Anti-phospho MEK1 pAb was purchased from Cell Signaling Technology. Secondary antibodies conjugated to alkaline phosphatase and their substrate NBT/BCIP were purchased from Promega. Secondary antibodies conjugated with rhodamine were from Jackson.
Buffers
Buer A: 50 mM b-glycerophosphate, pH 7.3, 1.5 mM EGTA, 1 mM EDTA, 1 mM dithiothreitol, 1 mM sodium orthovanadate. Buer H: Buer A containing 1 mM benzamidine, 10 mg/ml aprotinin, 10 mg/ml leupeptin, 1 mM PMSF, 2 mg/ml pepstatin A. Buer R (reaction mixture at threefold ®nal concentration): 30 mM MgCl 2 , 4.5 mM dithiothreitol, 75 mM b-glycerophosphate, pH 7.3, 0.15 mM sodium vanadate, 3.75 mM EGTA, 30 mM calmidazolum, 2.5 mg/ml bovine serum albumin.
Preparation of MEK1 mutants
Wild type and DN-EE MEK1 were subcloned into pCDNA1 as previously described (Jaaro et al., 1997; Seger et al., 1992b) .
GFP ± MEK1 was prepared as described (Rubinfeld et al., 1999) by PCR using wild type MEK1 in pcDNA1 (Seger et al., 1992b) as a template, T7 oligonucleotide as a sense and the oligonucleotide gatgggcccggacgccagcagcatgggttggtg as an antisense primers. The PCR product was ligated into HindIII and ApaI sites of pEGFP-N1 vector (CLONTECH). GFP-S218,222A-MEK1 and GFP-K97A-MEK1 were prepared as described for GFP ± MEK1 but S218,222A-MEK1 and K97A-MEK1 (Seger et al., 1994) were used instead of the wild type MEK1.
Cell culture and transfection
Rat1, HeLa and COS7 cells were grown in Dulbecco's modi®ed Eagle's medium (DMEM) supplemented with 10% foetal calf serum (FCS). The cells were serum starved using DMEM with 0.1% FCS for 18 h before treatment and harvest. The plasmids were introduced into Rat1 and HeLa cells with polyethylenimine (PEI, Boussif et al., 1995) . Brie¯y, the cells were seeded on coverslips in 6-well plates and grew to 50 ± 70% con¯uency. An aliquot of DNA (3 mg) was mixed with 50 ml of NaCl (150 mM) and mixed with PEI (15 ml 10 mM) in 35 ml of 150 mM NaCl. The mix was left at room temperature for 15 min and incubated with the cells for 90 min. Transfection of COS7 cells was carried out by DEAE-dextran as previously described (Jaaro et al., 1997) . Brie¯y, COS-7 cells were grown to approximately 60% con¯uency. Plasmid DNA (3 mg) and DE-Dextran (0.2 mg/ ml in PBS) were added to the COS7 cells for 30 min at 378C, followed by addition of DMEM containing 100 mM chloroquine and an additional incubation for 3 h. Then the solution was aspired and 10% DMSO in PBS was added for 1.5 min followed by a quick rinsing and incubation in normal growing conditions.
Immunofluorescent staining
Serum starved cells were treated with various stimuli and then washed with PBS and ®xed in 3% paraformaldehyde in PBS for 20 min (Jaaro et al., 1997) . For cells transfected with GFP ± MEK1, the coverslips were mounted at this stage and observed as below. For further immuno¯uorescent staining, the cells were permeabilized with 0.2% Triton X-100 for 5 min. Thereafter, the cells were incubated with anti-MEK1 C-18 antibody (1:50 for endogenous MEK1 or 1:100 for overexpressed MEK1) for 45 min followed by incubation with secondary antibodies conjugated with rhodamine for 45 min. The¯uorescence was observed under confocal microscope (BioRad).
Preparation of cell lysates and Western blot analysis
Rat1 cells in 6-cm plates were grown to subcon¯uence and then serum starved for 18 h. After treatment with various stimuli, the cells were washed twice with PBS and once with Buer A. The cells were harvested with 250 ml of Buer H and disrupted by sonication (2 pulses for 7 s of 50 watts). After centrifugation, the supernatants which contain cytosolic and nuclear protein were collected and separated in 10% SDS ± PAGE. The proteins were then transferred to the nitrocellulose membrane and detected by various antibodies.
ERK and MEK activity assays
ERK activity was determined using anti-di phospho ERK antibody and in vitro kinase assay (Yung et al., 1997) . For in vitro kinase assay, Rat1 cells were harvested and disrupted after stimulation. The ERK protein was pulled down by immunoprecipitation with anti-ERK1 C-16 antibody bound with protein-A beads. After two washes with RIPA buer, one with 0.5 M LiCl and two with Buer A, the beads were incubated with MBP (8.4 mg) and Buer R containing 100 mM [g-32 P]ATP (1 ± 2 c.p.m./fmol) in a ®nal volume of 30 ml for 15 min. The phosphorylated protein was separated in 15% SDS ± PAGE and the phosphate incorporation was detected by autoradiography. The phosphorylation (activation) of MEK1 was determined using anti phospho MEK antibody.
Abbreviations DP-ERK Ab, anti diphospho-ERK antibody; ERK, extracellular signal-regulated kinase; GFP, green¯uorescence protein; LMB, leptomycin B; MAPK, mitogen-activated protein kinase; MBP, myelin basic protein; MEK, MAPK/ ERK kinase; TPA, tetradecanoyl phorbol acetate
